1. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma
   Yong Liu et al, 2015, Tumor Biology CrossRef
2. SMYD3: a regulator of epigenetic and signaling pathways in cancer
   Benjamin J. Bernard et al, 2021, Clinical Epigenetics CrossRef
3. Cooperation between SMYD3 and PC4 drives a distinct transcriptional program in cancer cells
   Jin-Man Kim et al, 2015, Nucleic Acids Research CrossRef
4. Therapeutical potential of deregulated lysine methyltransferase SMYD3 as a safe target for novel anticancer agents
   Gurukumari Rajajeyabalachandran et al, 2017, Expert Opinion on Therapeutic Targets CrossRef
5. PRDI-BF1-RIZ domain of retinoblastoma protein-interacting zinc finger gene 1 induces apoptosis and exerts anticancer activity in esophageal squamous cell carcinoma cells
   SHANG-WEN DONG et al, 2015, Oncology Letters CrossRef
6. Playing on the Dark Side: SMYD3 Acts as a Cancer Genome Keeper in Gastrointestinal Malignancies
   Paola Sanese et al, 2021, Cancers CrossRef
7. Protein Lysine Methyltransferases Inhibitors
   Ying Li et al, 2023, Current Medicinal Chemistry CrossRef
8. Role of several histone lysine methyltransferases in tumor development
   JIFU LI et al, 2016, Biomedical Reports CrossRef
9. SETD3 is regulated by a couple of microRNAs and plays opposing roles in proliferation and metastasis of hepatocellular carcinoma
   Liangliang Xu et al, 2019, Clinical Science CrossRef
10. Epigenetic Alterations in Oesophageal Cancer: Expression and Role of the Involved Enzymes
    Nair Lopes et al, 2020, International Journal of Molecular Sciences CrossRef
11. Structure and Function of SET and MYND Domain-Containing Proteins
    Nicholas Spellmon et al, 2015, International Journal of Molecular Sciences CrossRef
12. Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation
    Michael J. Thomenius et al, 2018, PLOS ONE CrossRef
13. SMYD3: An Oncogenic Driver Targeting Epigenetic Regulation and Signaling Pathways
    Cinzia Bottino et al, 2020, Cancers CrossRef
14. SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma
    Ying Zhu et al, 2016, Human Pathology CrossRef
15. SMYD Protein Family as Promising Biomarkers for Cancer Diagnosis and Prognosis
    Yingxue Zhang et al, 2022, Genomic and Epigenomic Biomarkers of Toxicology and Disease CrossRef
16. A method for establishing a patient-derived xenograft model to explore new therapeutic strategies for esophageal squamous cell carcinoma
    YANAN JIANG et al, 2016, Oncology Reports CrossRef
17. The Critical Role of Hypoxic Microenvironment and Epigenetic Deregulation in Esophageal Cancer Radioresistance
    Catarina Macedo-Silva et al, 2019, Genes CrossRef
18. SMYD3 Promotes Cell Cycle Progression by Inducing Cyclin D3 Transcription and Stabilizing the Cyclin D1 Protein in Medulloblastoma
    Swapna Asuthkar et al, 2022, Cancers CrossRef
19. Amplification of SMYD3 promotes tumorigenicity and intrahepatic metastasis of hepatocellular carcinoma via upregulation of CDK2 and MMP2
    Yu Wang et al, 2019, Oncogene CrossRef
20. Critical roles of non-histone protein lysine methylation in human tumorigenesis
    Ryuji Hamamoto et al, 2015, Nature Reviews Cancer CrossRef
21. Small-molecule inhibitors of lysine methyltransferases SMYD2 and SMYD3: current trends
    Edoardo Fabini et al, 2019, Future Medicinal Chemistry CrossRef
22. Epigenetic modifications and regulations in gastrointestinal diseases
    Aditi Bhattacharya, 2023, Epigenetics in Organ Specific Disorders CrossRef